Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
N/A
Synonyms :
Tenidap, tenidapum
Class :
Anti-inflammatory agents/antirheumatics
the rate of excretion of abacavir may be reduced
the risk of hemorrhage and bleeding may be increased
the risk of adverse effects may be increased
the protein binding efficacy of acetohexamide may be reduced
the rate of excretion of acrivastine may be reduced
the risk of hypertension and kidney failure may increase
the risk of hypertension may be increased
the rate of excretion of amantadine may be reduced
the antihypertensive property of amlodipine may be reduced
the risk of adverse effects may be increased
the risk of hypertension, kidney failure, and hypokalemia may be increased
the risk of adverse effects may be increased
the antihypertensive property of betaxolol may be reduced
the therapeutic activity of bretylium may be reduced
the rate of excretion of carmustine may be reduced
the risk of nephrotoxicity may be increased
Actions and spectrum:Â
By the inhibition of interleukins and 5-LOX/COX-1, tenidap prevents inflammationÂ
Frequency definedÂ
Skin reactions (22%)Â
Frequency not definedÂ
HepatitisÂ
Disorders of the gastrointestinal systemÂ
Black Box Warning Â
Not listedÂ
Contraindication/Caution:Â
Contraindication:Â
Hypersensitivity Â
Hepatic failureÂ
Renal failureÂ
Pregnancy consideration:Â Â
USFDA pregnancy category: Not assignedÂ
Lactation:Â Â
The data about the excretion of tenidap into breast milk is not known.Â
Pregnancy category:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â
Tenidap is an anti-inflammatory and immunomodulatory drugÂ
Pharmacodynamics:Â
Tenidap inhibits the activity of the cyclooxygenase enzyme, leading to a decrease in the production of derivatives of arachidonic acid, thromboxanes, prostaglandins,Â
Pharmacokinetics:Â
Limited data availableÂ
Â
Administration:Â
It was not approved by the FDA due to harmful effects on prolonged use of a 120mg oral doseÂ
Patient information leafletÂ
Generic Name: tenidap Â
Why do we use tenidap?Â
Tenidap is an anti-inflammatory and antirheumatic agent. It is employed in the treatment of osteoarthritis and rheumatoid arthritis.Â